The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Postponement of Results and COVID 19 update

24 Mar 2020 07:00

RNS Number : 2934H
Ebiquity PLC
24 March 2020
 

Ebiquity PLC

 

("Ebiquity" or "the Company")

 

Postponement of Results and COVID 19 update

 

Following the request by the FCA that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks, the preliminary results for Ebiquity will be delayed from the previously planned date of publication on Thursday 26th March 2020. Notification of a new publication date will follow when further guidance from the FCA and other regulatory authorities is available.

 

Ebiquity's global business is continuing to deliver services to clients as usual, with staff in most of our offices worldwide now working remotely, supported by our global IT systems. We are pleased though that our staff in China and Singapore are now returning to office-based working.

 

As previously announced on 19 February 2020, Ebiquity's trading for the year ended 31 December 2019 was in line with expectations with the second half performance trend similar to the first half of the year. Whilst the audit is not yet complete, if announcing preliminary results today, Ebiquity would be expecting to report, on a going concern basis, revenue of £68.7 million and Adjusted Operating Profit of £6.2 million.

 

Following the disposal of Ad Intel in January 2019, Ebiquity has a considerably stronger balance sheet. Net debt at 31 December 2019 was £5.8 million, (compared to £28 million prior to the disposal of Ad Intel). At that date, its cash balances were £8.2m. The Group has committed banking facilities of £24 million, whose maturity date is in 2023, of which £14 million was drawn down as at 31 December 2019.

 

Trading in the current year has started in line with the Board's expectations. However, the rapidly developing Covid-19 global outbreak is clearly creating uncertainty over the coming months for our clients' businesses, which cover many sectors and geographies, as well as our own. The Board therefore believes it prudent at this stage to withdraw guidance on the Group's overall performance in 2020.

 

Rob Woodward, Chairman commented:

 

"We are extremely proud of all of our staff who have shown great resilience and flexibility in responding to the challenges of the Covid-19 outbreak. The Board thanks all Ebiquity's global teams for their continued commitment and determination to deliver high quality professional service and independent media advice to our clients during this difficult time."

 

 

Enquiries:

 

Ebiquity plc

Alan Newman (Interim Chief Executive Officer)

Mark Sanford (Company Secretary)

 

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Matt Lewis

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDGGDXSUDDGGX
Date   Source Headline
3rd Apr 20184:05 pmRNSHolding(s) in Company
21st Mar 20183:00 pmRNSDividend Declaration
21st Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20187:00 amRNSDirectorate Change
19th Feb 20187:00 amRNSIssue of Shares
13th Feb 20182:00 pmRNSDirector/PDMR dealing and grant of options
13th Feb 20187:00 amRNS£26m disposal and pre-close trading statement
2nd Jan 20184:45 pmRNSTotal Voting Rights
19th Dec 20177:00 amRNSDirectorate Change
28th Nov 201710:15 amRNSHolding(s) in Company
17th Nov 201712:01 pmRNSIssue of Shares
8th Nov 20173:00 pmRNSIssue of Shares
26th Sep 20177:00 amRNSInterim Results
19th Sep 20175:50 pmRNSHolding(s) in Company
31st Aug 20172:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNSIssue of Shares
21st Aug 20177:00 amRNSIssue of Shares
17th Aug 20178:52 amRNSIssue of Shares
8th Aug 20177:00 amRNSExercise of Share Options and dealing by PDMR
3rd Aug 20177:00 amRNSInterim trading statement
11th Jul 20177:00 amRNSEbiquity Launches Total View Attribution service
4th Jul 20177:00 amRNSEbiquity Launches Media Transparency Score tool
31st May 20171:00 pmRNSTotal Voting Rights
11th May 20175:05 pmRNSExercise of Share Options
10th May 201711:16 amRNSResult of AGM
2nd May 201711:05 amRNSDirector/PDMR Shareholding
21st Apr 20173:00 pmRNSAwards extension
20th Apr 20177:00 amRNSEbiquity launches 'Portfolio Digital' in the UK
18th Apr 201710:05 amRNSAnnual Report
29th Mar 201711:02 amRNSDividend Declaration
28th Mar 20177:00 amRNSFinal Results
10th Mar 20173:30 pmRNSHolding(s) in Company
26th Jan 20177:00 amRNSPre-close trading statement
2nd Dec 201612:15 pmRNSDeferred Consideration/Issue of Ordinary Shares
11th Nov 20162:48 pmRNSHolding(s) in Company
14th Oct 201612:30 pmRNSRe Directorate
6th Oct 20167:00 amRNSLaunch of Strategic Media Consultancy service
28th Sep 20167:00 amRNSInterim Results
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.